Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with

E

EGBOT

Guest
Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

HTML:
Pharmacyclics LLC today announced interim results from the ongoing Phase Ib/II PCYC-1129 study suggesting that ibrutinib (IMBRUVICA) may be a safe and effective treatment for patients with chronic graft-versus-host-disease (cGVHD) who were either refractory to steroid treatment or were steroid-dependent.

Source: Pharmacyclics? Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD
 

Create an account or login to comment

You must be a member in order to leave a comment

Create account

Create an account on our community. It's easy!

Log in

Already have an account? Log in here.

Similar threads

What Are Bodybuilding Peptides? The term “peptide” refers to any molecule that consists of...
Replies
0
Views
34
E
New, minimally invasive procedure may be effective for patients with FED A new, minimally...
Replies
0
Views
53
EGBOT
E

Latest threads

Back
Top